NovartisNOVN 
$96.51-1.14%24h
-1.14%24h
Global rank59
Market cap$198.38B
Change 7d-1.17%
YTD Performance0.60%
SP500 benchmarkUnderperform
P/E0
P/S4.25
Revenue$46.66B
Earnings$14.85B
Dividend yield3.7%
Main Sector
Healthcare
Novartis (NOVN) Total Liabilities
NOVN Total Liabilities in 2022: $53.20B
According to Novartis latest financial reports the total liabilities of NOVN is $53.20B, an decrease of -8.33% to 2022. At the end of 2022 company had $58.03B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Novartis is responsible for during its operational activities.
Novartis (NOVN) Total Liabilities History from 2023 to 2022
-
Value:-
NOVN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $53.20B | -8.33% |
| 2022 | $58.03B | -9.29% |
| 2021 | $63.97B | -10.04% |
| 2020 | $71.11B | 13.20% |
| 2019 | $62.82B | 58.32% |
| 2018 | $39.68B | - |
View the Top Total Liabilies Stocks
